πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12291530

GLP-1R agonist and therapeutic method thereof

Ascletis Pharma (China) Co., Limited Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12234236

GLP-1R agonist and therapeutic method thereof

Ascletis Pharma (China) Co., Limited Β· Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12215133

GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use

BrightGene Bio-Medical Technology Co., Ltd. Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12145974

Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12115225

GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof

Ionis Pharmaceuticals, Inc. Β· Granted Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11660328

GLP-2 analogs and peptibodies for administration before, during or after surgery

Takeda Pharmaceutical Company Limited Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10941187

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8853160

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580919

Polymer conjugates of GLP-1

Nektar Therapeutics Β· Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293869

Polymer conjugates of GLP-1

Nektar Therapeutics Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278272

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576050

GLP-1 exendin-4 peptide analogs and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276352

Induction of Ξ² cell differentiation in human cells by stimulation of the GLP-1 receptor

The Regents of the University of California Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056734

Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or ex

The United States of America, as represented by the Department of Health and Human Services, N.I.H. Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6884585

Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

The Regents of the University of California Β· Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired